O Conselho Nacional de Trânsito (Contran) aprovou hoje as novas regras para implementação de pedágios eletrônicos Free Flow em rodovias de todo o Brasil. Com este novo sistema, motoristas não ...

Nesta terça-feira (1), o Google anunciou o lançamento de dois novos Chromebooks em parceria com Samsung e Lenovo ...

O cearense Rubem Lins precisou sair de casa e ir para outra cidade, na tentativa de fugir de estragos maiores causados pela ...

Metal Gear Solid Δ: Snake Eater está programado para estrear no próximo ano, e mais uma vez contará com David Hayter como ...

Ozempic, the blockbuster diabetes shot made by Novo Nordisk A/S, is “very likely” to be one of the next drugs targeted for a price cut in bargaining with the US government’s Medicare program ...

O Google revelou hoje um novo recurso em colaboração com a Samsung, destacando a adição de uma tecla de inserção rápida ...

The top of executive of Novo Nordisk told a Senate panel Tuesday it was a "difficult choice" to discontinue the long-acting insulin Levemir but he had to do so because of market forces.

Bernie Sanders called "outrageously high" prices for the drugs. Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee ...

O Google, juntamente com a Samsung e a Lenovo, lançaram novos Chromebooks, e o modelo Samsung Galaxy Chromebook Plus recebeu ...

Sept 23 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic will be eligible for U.S. government's price negotiations in less than a year based on current criteria, the Danish drugmaker's ...

While the uninspiring weight loss numbers coupled with neuropsychiatric side effects may appear to put a dent into Novo’s post-Wegovy obesity strategy, the company was clear in the release that ...

Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen will use a familiar argument to defend the US prices of blockbuster drugs Ozempic and Wegovy when he appears Tuesday before a ...